Next-Generation Sequencing Data Analysis Market: Global Industry Analysis and Forecast (2022-2029)


Next-Generation Sequencing Data Analysis Market is expected to reach USD 58333.64 million at a CAGR of 18% during the forecast period 2029.

The global Next-Generation Sequencing Data Analysis Market report is a comprehensive analysis of the industry, market, and key players. The report has covered the market by demand and supply-side by segments. The global Next-Generation Se6quencing Data Analysis report also provides trends by market segments, technology, and investment with a competitive landscape.

Next-Generation Sequencing Data Analysis Market

To know about the Research Methodology :- Request Free Sample Report

Next-Generation Sequencing Data Analysis Market Overview:

NGS, also known as high throughput sequencing, is a concept that is used to describe a variety of advanced sequencing technologies. Due to the high throughput, scalability, and speed of next-generation sequencing, researchers can investigate biological processes in depth. Because of the complexities involved in genomic science, a higher degree of understanding is now needed than that provided by traditional DNA sequencing methods.

As a result, next-generation sequencing has filled in the holes to meet these higher-level understanding requirements and has become a popular analysis method. The scalability of next-generation sequencing allows for changing the level of precision to satisfy laboratory needs, making it a digital alternative to sequence-based gene expression.

The use of NGS approaches in conjunction with the clinical diagnosis for customized treatment of many disorders, as well as genomic testing, necessitates the development of fast and accurate algorithms and sequencing visualization techniques that can process data more quickly.

Next-Generation Sequencing Data Analysis Market Dynamics:


Drivers:

Next-generation sequencing has aided in the investigation of epigenomic and genomic patterns linked to a variety of biological processes. Storage, maintenance, and accessing knowledge issues are projected to create future R&D opportunities for the sector, resulting in market growth. Laboratory Information Management Systems (LIMS) are needed for the handling and archiving of sequencing data in research communities that use high-throughput sequencers.

NGS methods have been used extensively in oncology precision medicine, primarily for lung and breast cancers. To improve their markets, companies are now concentrating on creating low-cost genome sequencing solutions.

Cloud-based platforms are a good choice for computationally intensive activities like NGS data processing. As a result, acquiring computing resources to perform large-scale NGS data analysis has become a fast and simple method. As a result, the market is projected to be driven by the growth of cloud-based bioinformatics platforms and services for large-scale NGS data processing.

Furthermore, owing to the high genetic data production and concurrent decrease in sequencing costs, the scale of sequencing ventures is expected to expand. As a result, there is a greater need for complex bioinformatics pipelines with cutting-edge and effective solutions.

Restraints:

However, the expense of infrastructural advancement of algorithms and applications is expected to stifle demand growth to some degree. Furthermore, the time-consuming aspect of NGS data collection is stifling the market's expansion. Commercial service providers, on the other hand, would have lucrative opportunities to build and build newer technologies and shorter delivery times as a result of this.

Next-Generation Sequencing Data Analysis Market Segment Analysis:

Based on Product, the services dominated the global next-generation sequencing data analysis industry with sales over 54% in 2020. Establishments that lack the necessary resources for data management, research, and interpretation readily implement cost-effective NGS data analysis services. Exome interpretation, variant calling, visualization, annotation, and other resources are available from companies including ThermoFisher Scientific, Igenbio, Inc, and Toldot Genetics.
QIAGEN's CLC Genomics Workbench is a data interpretation platform that combines epigenomics, genomics, metagenomics, and transcriptomics into a single application.

Based on Workflow, the tertiary workflow division led the sector with a market share of over 48% in 2020. For NGS tertiary data processing, a variety of annotation methods are used, and organizations are taking strategic steps to extend the reach of these tools.

Field-programmable gate arrays (FPGAs) are logic circuits that are more efficient and faster than traditional CPUs, making them ideal for personalized genomic analysis. Cloud service providers, such as Amazon Web Services, have massive storage centers with the capacity to handle a large number of samples at the same time.

Based on Mode, the in-house mode division accounted for over 65 percent of total sales, in 2020. Companies that use NGS for disease testing and evaluation while doing their research using available hardware and software resources are considered in-house. The number of these businesses is exponentially growing. Furthermore, many universities and scientific institutes' annual allocations for in-house data processing are more than double those of outsourced data analysis.

The in-house research also enables bioinformatics pipelines to quickly incorporate novel experimental workflows. These variables account for the majority of this segment's revenue, and they are expected to continue to do so during the projected period.

Based on Reading Length, the short-read sequencing held a 77.37 % share of the global market in 2020 owing to the widespread acceptance and availability of alignment instruments and algorithms for short-read sequencing results. BaseSpace Sequence Hub is a cloud computing environment for genomics that provides a series of short-read sequencing data processing software that can be used in a variety of experiments and can ease the management of sequencing data. Long and very long read sequencing segments demonstrate promising market potential. Guppy is a data processing toolkit from Oxford Nanopore that provides bioinformatic post-processing functionality and base-calling algorithms.

Based on End User, the academic institutes and research centers made significant improvements in 2020 due to an increase in the implementation of next-generation sequencing data processing workflows in academic institutions. For example, To help researchers with their ongoing academic research and programs, the University of Pittsburgh has developed centers for sequencing, bioinformatics processing, and high-performance computing.

Next-Generation Sequencing Data Analysis Market Regional Insights:

In 2020, North America had a commanding share of 50.03 percent. This is due to the involvement of a large number of major players, including Illumina, Thermo Fisher Scientific, Agilent Technologies, and several companies that use data processing tools.

However, in the coming years, Asia Pacific is expected to rise significantly in this region. This is mostly attributed to an increase in the number of grants awarded for sequencing programs in this region's developed countries. This is mostly attributed to an increase in the number of grants awarded for sequencing programs in this region's developed countries.

Furthermore, promising R&D results that encourage the use of high-throughput sequencing in clinical diagnosis are expected to drive the NGS data sequencing market in the Asia Pacific to new heights.

The objective of the report is to present a comprehensive analysis of the global Next-Generation Sequencing Data Analysis Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants.

PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.

The report also helps in understanding the global Next-Generation Sequencing Data Analysis Market dynamics, structure by analyzing the market segments and project the global Next-Generation Sequencing Data Analysis Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the global Next-Generation Sequencing Data Analysis Market make the report investor’s guide.

Next-Generation Sequencing Data Analysis Market Key Developments:

Nebula Genomics, a Harvard University spinoff, unveiled an at-home whole genome sequencing test in February 2020. This test will give you a readout of a person's whole genetic code.
Saphetor SA and Paragon Genomics announced a collaboration in May 2020 to create and commercialize VarSome, a bioinformatics solution for accurate and quick variant detection, annotation, and analysis of NGS-generated data.
Illumina teamed up with Helix in January 2021 to use its sequencing technologies to test the Latest SARS-CoV-2 U.K. Variant (B.1.1.7) in the United States.

Next-Generation Sequencing Data Analysis Market Scope: Inquire before buying


Next-Generation Sequencing Data Analysis Market, by Product

 Services
 NGS Commercial Software
 Platform OS/UI
 Analytical Software
o Alignment Tools & Softwares
 DNA Sequence Alignment
 RNA Sequence Alignment
 Protein Sequence Alignment
o QC/Pre-processing Tools
o Others

Next-Generation Sequencing Data Analysis Market, by Workflow

 Primary
 Secondary
 Read Mapping
 Variant Alignment & Variant Calling
 Tertiary
 Variant Annotation
 Application-Specific
o Targeted Sequencing
o Exome Sequencing
o RNA Sequencing
o Whole Genome Sequencing
o CHIP-Sequencing
o Others

Next-Generation Sequencing Data Analysis Market, by Mode

 In-house
 Outsourced

Next-Generation Sequencing Data Analysis Market, by Read Length

 Short Read
 Long Read
 Very Long Read

Next-Generation Sequencing Data Analysis Market, by End User

 Academic Research
 Clinical Research
 Hospitals & Clinics
 Pharma & Biotech Entities
 Other End Users

Next-Generation Sequencing Data Analysis Market, by Region

 North America
 Europe
 Asia Pacific
 The Middle East and Africa
 South America

Next-Generation Sequencing Data Analysis Market Key Players
Thermo Fisher Scientific, Inc.
 Illumina, Inc.
 QIAGEN
 F. Hoffman-La Roche Technologies
 Agilent Technologies
 Intrexon Bioinformatics Germany GmbH
 Partek, Inc.
 PierianDx
 DNASTAR, Inc.
 Eurofins Scientific
 Congenica Ltd.
 Bio Rad Laboratories, Inc.
 Genuity Science
 DNAnexus Inc.
 SciGenom Labs Pvt. Ltd
 Golden Helix, Inc.
 Other Key Players

Frequently Asked Questions:

1. What is the growth rate of Global Next-Generation Sequencing Data Analysis Market?
Ans: The Global Next-Generation Sequencing Data Analysis Market is growing at a CAGR of 18% during forecasting period 2022-2029.

2. What is scope of the Global Next-Generation Sequencing Data Analysis market report?
Ans: Global Next-Generation Sequencing Data Analysis Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.

3. Who are the key players in Global Next-Generation Sequencing Data Analysis market?
Ans: The important key players in the Global Next-Generation Sequencing Data Analysis Market are – Thermo Fisher Scientific, Inc., Illumina, Inc., QIAGEN, F. Hoffman-La Roche Technologies, Agilent Technologies, Intrexon Bioinformatics Germany GmbH, Partek, Inc., PierianDx, DNASTAR, Inc., Eurofins Scientific, Congenica Ltd., Bio Rad Laboratories, Inc., Genuity Science, DNAnexus Inc., SciGenom Labs Pvt. Ltd, Golden Helix, Inc., and Other Key Players

4. What is the study period of this market?
Ans: The Global Next-Generation Sequencing Data Analysis Market is studied from 2021 to 2029. 




1.Preface
1.1. Market Definition and Key Research Objectives
1.2. Research Highlights
2. Assumptions and Research Methodology
2.1. Report Assumptions
2.2. Abbreviations
2.3. Research Methodology
2.3.1. Secondary Research
2.3.1.1. Secondary data
2.3.1.2. Secondary Sources
2.3.2. Primary Research
2.3.2.1. Data from Primary Sources
2.3.2.2. Breakdown of Primary Sources
3. Executive Summary: Global Next-Generation Sequencing Data Analysis Market Size, by Market Value (US$ Mn)
3.1. Global Market Segmentation
3.2. Global Market Segmentation Share Analysis, 2021
3.2.1. Global
3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa)
3.3. Geographical Snapshot of the Next-Generation Sequencing Data Analysis Market
3.4. Geographical Snapshot of the Next-Generation Sequencing Data Analysis Market, By Manufacturer share
4. Global Next-Generation Sequencing Data Analysis Market Overview, 2021-2029
4.1. Market Dynamics
4.1.1. Drivers
4.1.1.1. Global
4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa)
4.1.2. Restraints
4.1.2.1. Global
4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa)
4.1.3. Opportunities
4.1.3.1. Global
4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa)
4.1.4. Challenges
4.1.4.1. Global
4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa)
4.1.5. Industry Trends and Emerging Technologies
4.1.6. Porters Five Forces Analysis
4.1.6.1. Threat of New Entrants
4.1.6.2. Bargaining Power of Buyers/Consumers
4.1.6.3. Bargaining Power of Suppliers
4.1.6.4. Threat of Substitute Products
4.1.6.5. Intensity of Competitive Rivalry
4.1.7. Value Chain Analysis
4.1.8. Technological Roadmap
4.1.9. Regulatory landscape
4.1.10. Impact of the Covid-19 Pandemic on the Global Next-Generation Sequencing Data Analysis Market
5. Supply Side and Demand Side Indicators
6. Global Next-Generation Sequencing Data Analysis Market Analysis and Forecast, 2021-2029
6.1. Global Next-Generation Sequencing Data Analysis Market Size & Y-o-Y Growth Analysis.
7. Global Next-Generation Sequencing Data Analysis Market Analysis and Forecasts, 2021-2029
7.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029
7.1.1. Services
7.1.2. NGS Commercial Software
7.1.2.1. Platform OS/UI
7.1.2.2. Analytical Software
7.1.2.2.1. Alignment Tools & Softwares
7.1.2.2.1.1. DNA Sequence Alignment
7.1.2.2.1.2. RNA Sequence Alignment
7.1.2.2.1.3. Protein Sequence Alignment
7.1.2.3. QC/Pre-processing Tools
7.1.2.4. Others
7.2. Market Size (Value) Estimates & Forecast By Workflow, 2021-2029
7.2.1. Primary
7.2.2. Secondary
7.2.2.1. Read Mapping
7.2.2.2. Variant Alignment & Variant Calling
7.2.3. Tertiary
7.2.3.1. Variant Annotation
7.2.3.2. Application-Specific
7.2.3.2.1. Targeted Sequencing
7.2.3.2.2. Exome Sequencing
7.2.3.2.3. RNA Sequencing
7.2.3.2.4. Whole Genome Sequencing
7.2.3.2.5. CHIP-Sequencing
7.2.3.2.6. Others
7.3. Market Size (Value) Estimates & Forecast By Mode, 2021-2029
7.3.1. In-house
7.3.2. Outsourced
7.4. Market Size (Value) Estimates & Forecast By Read Length, 2021-2029
7.4.1. Short Read
7.4.2. Long Read
7.4.3. Very Long Read
7.5. Market Size (Value) Estimates & Forecast By End users, 2021-2029
7.5.1. Academic Research
7.5.2. Clinical Research
7.5.3. Hospitals & Clinics
7.5.4. Pharma & Biotech Entities
7.5.5. Other End Users
8. Global Next-Generation Sequencing Data Analysis Market Analysis and Forecasts, By Region
8.1. Market Size (Value) Estimates & Forecast By Region, 2021-2029
8.1.1. North America
8.1.2. Europe
8.1.3. Asia-Pacific
8.1.4. Middle East & Africa
8.1.5. South America
9. North America Next-Generation Sequencing Data Analysis Market Analysis and Forecasts, 2021-2029
9.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029
9.1.1. Services
9.1.2. NGS Commercial Software
9.1.2.1. Platform OS/UI
9.1.2.2. Analytical Software
9.1.2.2.1. Alignment Tools & Softwares
9.1.2.2.2. DNA Sequence Alignment
9.1.2.2.3. RNA Sequence Alignment
9.1.2.2.4. Protein Sequence Alignment
9.1.2.3. QC/Pre-processing Tools
9.1.2.4. Others
9.2. Market Size (Value) Estimates & Forecast By Workflow, 2021-2029
9.2.1. Primary
9.2.2. Secondary
9.2.2.1. Read Mapping
9.2.2.2. Variant Alignment & Variant Calling
9.2.3. Tertiary
9.2.3.1. Variant Annotation
9.2.3.2. Application-Specific
9.2.3.2.1. Targeted Sequencing
9.2.3.2.2. Exome Sequencing
9.2.3.2.3. RNA Sequencing
9.2.3.2.4. Whole Genome Sequencing
9.2.3.2.5. CHIP-Sequencing
9.2.3.2.6. Others
9.3. Market Size (Value) Estimates & Forecast By Mode, 2021-2029
9.3.1. In-house
9.3.2. Outsourced
9.4. Market Size (Value) Estimates & Forecast By Read Length, 2021-2029
9.4.1. Short Read
9.4.2. Long Read
9.4.3. Very Long Read
9.5. Market Size (Value) Estimates & Forecast By End users, 2021-2029
9.5.1. Academic Research
9.5.2. Clinical Research
9.5.3. Hospitals & Clinics
9.5.4. Pharma & Biotech Entities
9.5.5. Other End Users
10. North America Next-Generation Sequencing Data Analysis Market Analysis and Forecasts, By Country
10.1. Market Size (Value) Estimates & Forecast By Country, 2021-2029
10.1.1. US
10.1.2. Canada
10.1.3. Mexico
11. U.S. Next-Generation Sequencing Data Analysis Market Analysis and Forecasts, 2021-2029
11.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029
11.2. Market Size (Value) Estimates & Forecast By Workflow, 2021-2029
11.3. Market Size (Value) Estimates & Forecast By Mode, 2021-2029
11.4. Market Size (Value) Estimates & Forecast By Read Length, 2021-2029
11.5. Market Size (Value) Estimates & Forecast By End users, 2021-2029
12. Canada Next-Generation Sequencing Data Analysis Market Analysis and Forecasts, 2021-2029
12.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029
12.2. Market Size (Value) Estimates & Forecast By Workflow, 2021-2029
12.3. Market Size (Value) Estimates & Forecast By Mode, 2021-2029
12.4. Market Size (Value) Estimates & Forecast By Read Length, 2021-2029
12.5. Market Size (Value) Estimates & Forecast By End users, 2021-2029
13. Mexico Next-Generation Sequencing Data Analysis Market Analysis and Forecasts, 2021-2029
13.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029
13.2. Market Size (Value) Estimates & Forecast By Workflow, 2021-2029
13.3. Market Size (Value) Estimates & Forecast By Mode, 2021-2029
13.4. Market Size (Value) Estimates & Forecast By Read Length, 2021-2029
13.5. Market Size (Value) Estimates & Forecast By End users, 2021-2029
14. Europe Next-Generation Sequencing Data Analysis Market Analysis and Forecasts, 2021-2029
14.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029
14.2. Market Size (Value) Estimates & Forecast By Workflow, 2021-2029
14.3. Market Size (Value) Estimates & Forecast By Mode, 2021-2029
14.4. Market Size (Value) Estimates & Forecast By Read Length, 2021-2029
14.5. Market Size (Value) Estimates & Forecast By End users, 2021-2029
15. Europe Next-Generation Sequencing Data Analysis Market Analysis and Forecasts, By Country
15.1. Market Size (Value) Estimates & Forecast By Country, 2021-2029
15.1.1. U.K
15.1.2. France
15.1.3. Germany
15.1.4. Italy
15.1.5. Spain
15.1.6. Sweden
15.1.7. CIS Countries
15.1.8. Rest of Europe
16. U.K. Next-Generation Sequencing Data Analysis Market Analysis and Forecasts, 2021-2029
16.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029
16.2. Market Size (Value) Estimates & Forecast By Workflow, 2021-2029
16.3. Market Size (Value) Estimates & Forecast By Mode, 2021-2029
16.4. Market Size (Value) Estimates & Forecast By Read Length, 2021-2029
16.5. Market Size (Value) Estimates & Forecast By End users, 2021-2029
17. France Next-Generation Sequencing Data Analysis Market Analysis and Forecasts, 2021-2029
17.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029
17.2. Market Size (Value) Estimates & Forecast By Workflow, 2021-2029
17.3. Market Size (Value) Estimates & Forecast By Mode, 2021-2029
17.4. Market Size (Value) Estimates & Forecast By Read Length, 2021-2029
17.5. Market Size (Value) Estimates & Forecast By End users, 2021-2029
18. Germany Next-Generation Sequencing Data Analysis Market Analysis and Forecasts, 2021-2029
18.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029
18.2. Market Size (Value) Estimates & Forecast By Workflow, 2021-2029
18.3. Market Size (Value) Estimates & Forecast By Mode, 2021-2029
18.4. Market Size (Value) Estimates & Forecast By Read Length, 2021-2029
18.5. Market Size (Value) Estimates & Forecast By End users, 2021-2029
19. Italy Next-Generation Sequencing Data Analysis Market Analysis and Forecasts, 2021-2029
19.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029
19.2. Market Size (Value) Estimates & Forecast By Workflow, 2021-2029
19.3. Market Size (Value) Estimates & Forecast By Mode, 2021-2029
19.4. Market Size (Value) Estimates & Forecast By Read Length, 2021-2029
19.5. Market Size (Value) Estimates & Forecast By End users, 2021-2029
20. Spain Next-Generation Sequencing Data Analysis Market Analysis and Forecasts, 2021-2029
20.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029
20.2. Market Size (Value) Estimates & Forecast By Workflow, 2021-2029
20.3. Market Size (Value) Estimates & Forecast By Mode, 2021-2029
20.4. Market Size (Value) Estimates & Forecast By Read Length, 2021-2029
20.5. Market Size (Value) Estimates & Forecast By End users, 2021-2029
21. Sweden Next-Generation Sequencing Data Analysis Market Analysis and Forecasts, 2021-2029
21.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029
21.2. Market Size (Value) Estimates & Forecast By Workflow, 2021-2029
21.3. Market Size (Value) Estimates & Forecast By Mode, 2021-2029
21.4. Market Size (Value) Estimates & Forecast By Read Length, 2021-2029
21.5. Market Size (Value) Estimates & Forecast By End users, 2021-2029
22. CIS Countries Next-Generation Sequencing Data Analysis Market Analysis and Forecasts, 2021-2029
22.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029
22.2. Market Size (Value) Estimates & Forecast By Workflow, 2021-2029
22.3. Market Size (Value) Estimates & Forecast By Mode, 2021-2029
22.4. Market Size (Value) Estimates & Forecast By Read Length, 2021-2029
22.5. Market Size (Value) Estimates & Forecast By End users, 2021-2029
23. Rest of Europe Next-Generation Sequencing Data Analysis Market Analysis and Forecasts, 2021-2029
23.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029
23.2. Market Size (Value) Estimates & Forecast By Workflow, 2021-2029
23.3. Market Size (Value) Estimates & Forecast By Mode, 2021-2029
23.4. Market Size (Value) Estimates & Forecast By Read Length, 2021-2029
23.5. Market Size (Value) Estimates & Forecast By End users, 2021-2029
24. Asia Pacific Next-Generation Sequencing Data Analysis Market Analysis and Forecasts, 2021-2029
24.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029
24.2. Market Size (Value) Estimates & Forecast By Workflow, 2021-2029
24.3. Market Size (Value) Estimates & Forecast By Mode, 2021-2029
24.4. Market Size (Value) Estimates & Forecast By Read Length, 2021-2029
24.5. Market Size (Value) Estimates & Forecast By End users, 2021-2029
25. Asia Pacific Next-Generation Sequencing Data Analysis Market Analysis and Forecasts, by Country
25.1. Market Size (Value) Estimates & Forecast By Country, 2021-2029
25.1.1. China
25.1.2. India
25.1.3. Japan
25.1.4. South Korea
25.1.5. Australia
25.1.6. ASEAN
25.1.7. Rest of Asia Pacific
26. China Next-Generation Sequencing Data Analysis Market Analysis and Forecasts, 2021-2029
26.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029
26.2. Market Size (Value) Estimates & Forecast By Workflow, 2021-2029
26.3. Market Size (Value) Estimates & Forecast By Mode, 2021-2029
26.4. Market Size (Value) Estimates & Forecast By Read Length, 2021-2029
26.5. Market Size (Value) Estimates & Forecast By End users, 2021-2029
27. India Next-Generation Sequencing Data Analysis Market Analysis and Forecasts, 2021-2029
27.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029
27.2. Market Size (Value) Estimates & Forecast By Workflow, 2021-2029
27.3. Market Size (Value) Estimates & Forecast By Mode, 2021-2029
27.4. Market Size (Value) Estimates & Forecast By Read Length, 2021-2029
27.5. Market Size (Value) Estimates & Forecast By End users, 2021-2029
28. Japan Next-Generation Sequencing Data Analysis Market Analysis and Forecasts, 2021-2029
28.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029
28.2. Market Size (Value) Estimates & Forecast By Workflow, 2021-2029
28.3. Market Size (Value) Estimates & Forecast By Mode, 2021-2029
28.4. Market Size (Value) Estimates & Forecast By Read Length, 2021-2029
28.5. Market Size (Value) Estimates & Forecast By End users, 2021-2029
29. South Korea Next-Generation Sequencing Data Analysis Market Analysis and Forecasts, 2021-2029
29.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029
29.2. Market Size (Value) Estimates & Forecast By Workflow, 2021-2029
29.3. Market Size (Value) Estimates & Forecast By Mode, 2021-2029
29.4. Market Size (Value) Estimates & Forecast By Read Length, 2021-2029
29.5. Market Size (Value) Estimates & Forecast By End users, 2021-2029
30. Australia Next-Generation Sequencing Data Analysis Market Analysis and Forecasts, 2021-2029
30.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029
30.2. Market Size (Value) Estimates & Forecast By Workflow, 2021-2029
30.3. Market Size (Value) Estimates & Forecast By Mode, 2021-2029
30.4. Market Size (Value) Estimates & Forecast By Read Length, 2021-2029
30.5. Market Size (Value) Estimates & Forecast By End users, 2021-2029
31. ASEAN Next-Generation Sequencing Data Analysis Market Analysis and Forecasts, 2021-2029
31.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029
31.2. Market Size (Value) Estimates & Forecast By Workflow, 2021-2029
31.3. Market Size (Value) Estimates & Forecast By Mode, 2021-2029
31.4. Market Size (Value) Estimates & Forecast By Read Length, 2021-2029
31.5. Market Size (Value) Estimates & Forecast By End users, 2021-2029
32. Rest of Asia Pacific Next-Generation Sequencing Data Analysis Market Analysis and Forecasts, 2021-2029
32.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029
32.2. Market Size (Value) Estimates & Forecast By Workflow, 2021-2029
32.3. Market Size (Value) Estimates & Forecast By Mode, 2021-2029
32.4. Market Size (Value) Estimates & Forecast By Read Length, 2021-2029
32.5. Market Size (Value) Estimates & Forecast By End users, 2021-2029
33. Middle East Africa Next-Generation Sequencing Data Analysis Market Analysis and Forecasts, 2021-2029
33.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029
33.2. Market Size (Value) Estimates & Forecast By Workflow, 2021-2029
33.3. Market Size (Value) Estimates & Forecast By Mode, 2021-2029
33.4. Market Size (Value) Estimates & Forecast By Read Length, 2021-2029
33.5. Market Size (Value) Estimates & Forecast By End users, 2021-2029
34. Middle East Africa Next-Generation Sequencing Data Analysis Market Analysis and Forecasts, by Country
34.1. Market Size (Value) Estimates & Forecast by Country, 2021-2029
34.1.1. South Africa
34.1.2. GCC Countries
34.1.3. Egypt
34.1.4. Nigeria
34.1.5. Rest of ME&A
35. South Africa Next-Generation Sequencing Data Analysis Market Analysis and Forecasts, 2021-2029
35.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029
35.2. Market Size (Value) Estimates & Forecast By Workflow, 2021-2029
35.3. Market Size (Value) Estimates & Forecast By Mode, 2021-2029
35.4. Market Size (Value) Estimates & Forecast By Read Length, 2021-2029
35.5. Market Size (Value) Estimates & Forecast By End users, 2021-2029
36. GCC Countries Next-Generation Sequencing Data Analysis Market Analysis and Forecasts, 2021-2029
36.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029
36.2. Market Size (Value) Estimates & Forecast By Workflow, 2021-2029
36.3. Market Size (Value) Estimates & Forecast By Mode, 2021-2029
36.4. Market Size (Value) Estimates & Forecast By Read Length, 2021-2029
36.5. Market Size (Value) Estimates & Forecast By End users, 2021-2029
37. Egypt Next-Generation Sequencing Data Analysis Market Analysis and Forecasts, 2021-2029
37.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029
37.2. Market Size (Value) Estimates & Forecast By Workflow, 2021-2029
37.3. Market Size (Value) Estimates & Forecast By Mode, 2021-2029
37.4. Market Size (Value) Estimates & Forecast By Read Length, 2021-2029
37.5. Market Size (Value) Estimates & Forecast By End users, 2021-2029
38. Nigeria Next-Generation Sequencing Data Analysis Market Analysis and Forecasts, 2021-2029
38.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029
38.2. Market Size (Value) Estimates & Forecast By Workflow, 2021-2029
38.3. Market Size (Value) Estimates & Forecast By Mode, 2021-2029
38.4. Market Size (Value) Estimates & Forecast By Read Length, 2021-2029
38.5. Market Size (Value) Estimates & Forecast By End users, 2021-2029
39. Rest of ME&A Next-Generation Sequencing Data Analysis Market Analysis and Forecasts, 2021-2029
39.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029
39.2. Market Size (Value) Estimates & Forecast By Workflow, 2021-2029
39.3. Market Size (Value) Estimates & Forecast By Mode, 2021-2029
39.4. Market Size (Value) Estimates & Forecast By Read Length, 2021-2029
39.5. Market Size (Value) Estimates & Forecast By End users, 2021-2029
40. South America Next-Generation Sequencing Data Analysis Market Analysis and Forecasts, 2021-2029
40.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029
40.2. Market Size (Value) Estimates & Forecast By Workflow, 2021-2029
40.3. Market Size (Value) Estimates & Forecast By Mode, 2021-2029
40.4. Market Size (Value) Estimates & Forecast By Read Length, 2021-2029
40.5. Market Size (Value) Estimates & Forecast By End users, 2021-2029
41. South America Next-Generation Sequencing Data Analysis Market Analysis and Forecasts, by Country
41.1. Market Size (Value) Estimates & Forecast by Country, 2021-2029
41.1.1. Brazil
41.1.2. Argentina
41.1.3. Rest of South America
42. Brazil Next-Generation Sequencing Data Analysis Market Analysis and Forecasts, 2021-2029
42.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029
42.2. Market Size (Value) Estimates & Forecast By Workflow, 2021-2029
42.3. Market Size (Value) Estimates & Forecast By Mode, 2021-2029
42.4. Market Size (Value) Estimates & Forecast By Read Length, 2021-2029
42.5. Market Size (Value) Estimates & Forecast By End users, 2021-2029
43. Argentina Next-Generation Sequencing Data Analysis Market Analysis and Forecasts, 2021-2029
43.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029
43.2. Market Size (Value) Estimates & Forecast By Workflow, 2021-2029
43.3. Market Size (Value) Estimates & Forecast By Mode, 2021-2029
43.4. Market Size (Value) Estimates & Forecast By Read Length, 2021-2029
43.5. Market Size (Value) Estimates & Forecast By End users, 2021-2029
44. Rest of South America Next-Generation Sequencing Data Analysis Market Analysis and Forecasts, 2021-2029
44.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029
44.2. Market Size (Value) Estimates & Forecast By Workflow, 2021-2029
44.3. Market Size (Value) Estimates & Forecast By Mode, 2021-2029
44.4. Market Size (Value) Estimates & Forecast By Read Length, 2021-2029
44.5. Market Size (Value) Estimates & Forecast By End users, 2021-2029
45. Competitive Landscape
45.1. Geographic Footprint of Major Players in the Global Next-Generation Sequencing Data Analysis Market
45.2. Competition Matrix
45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Modes and R&D Investment
45.2.2. New Product Launches and Product Enhancements
45.2.3. Market Consolidation
45.2.3.1. M&A by Regions, Investment and Verticals
45.2.3.2. M&A, Forward Integration and Backward
Integration
45.2.3.3. Partnership, Joint Ventures, and Strategic Alliances/ Sales Agreements
45.3. Company Profile: Key Players
45.3.1. Thermo Fisher Scientific, Inc.
45.3.1.1. Company Overview
45.3.1.2. Financial Overview
45.3.1.3. Geographic Footprint
45.3.1.4. Product Portfolio
45.3.1.5. Business Strategy
45.3.1.6. Recent Developments
45.3.2. Illumina, Inc.
45.3.3. QIAGEN
45.3.4. F. Hoffman-La Roche Technologies
45.3.5. Agilent Technologies
45.3.6. Intrexon Bioinformatics Germany GmbH
45.3.7. Partek, Inc.
45.3.8. PierianDx
45.3.9. DNASTAR, Inc.
45.3.10. Eurofins Scientific
45.3.11. Congenica Ltd.
45.3.12. Bio Rad Laboratories, Inc.
45.3.13. Genuity Science
45.3.14. DNAnexus Inc.
45.3.15. SciGenom Labs Pvt. Ltd
45.3.16. Golden Helix, Inc.
45.3.17. Other Key Players
46. Primary Key Insights
  • INQUIRE BEFORE BUYING